Member Info for MrHumble

WE could make the argument that is is to create value?

14th October 2020

4 million raised

11% dilution

16p per share

Nearly 5 years on, same price - circa same raise - same hopes?

Great outlooks guys

I am just a bit concerned that the only thing none of you forecasted - and no 'clues' given for - and the only real occurrence - was a spike and cash raise.

Next it will be a crda nda with a client order... just to keep the comedy going

'As expected' ..It is a term that rules out uncertainty at the present time. So he is certain you are going to get F all of note any time soon as well. Or again, it had to be disclosed

So assuming the general rules apply and he is not above them, you can put this one to bed - and focus on something else . Oh - Superdrug - JIT

Lots of concrete numbers next week. Cant wait.

I can think of at least 12 -16 details you should have now - now. The cact you do not, says it all

But it is AIM so can I delete all those? haha

Not even have to have received money you know. 'As expected' (only can be measured against internal benchmarks - which you should actually know despite NDA) , would also include an expected (not received) amount in the future - whether that expectation set by CRDA or SBTX own benchmarks. So really the medium term seems to have immaterial return at the mo

Are crap

So forget about 'big cheque received' if the cash raise did not make you do so already.

It also highlights that SBTX internal forecasts and crap. If 'as expected' was material - have to give impact

If he knows of significant loss, or profit/royalties- he cant keep in-house. It is an obligatory instant release. He would not disclose unit sales, or margin's etc, but would have to disclose 'material impact' . There is no NDA that can override that. I checked if true for AIM as I was not sure. It is true CRDA would have to o same if material to them

But when does this arrangement expire? It is a deal/contract right?

\He is not withholding info you all hope for, unless illegally,

It's that simple

The critical question is whether information is "inside information" under Market Abuse Regulation - if it's specific, precise, and would materially affect the share price if known, it must be disclosed regardless of NDAs.

............

So no news

Also Key timeframes that affect the company's prospects, even if NDA details remain confidential

There is a lot of stuff you would have to disclose no matter what the NDA, unless not material, which isn't great

If the deal could materially affect revenues, profits, or financial position, the scale/significance must be disclosed, whatever the NDA terms

The absence of an NDA end-date doesn't exempt them from immediate disclosure of price-sensitive information - regulatory obligations always trump contractual confidentiality agreements. So the 'as expected' was obviously ppor

What is the duration/time to expiry for the current SBTX/Croda deal

Unfortunately now for the bad news,. Due to no influence from me whatsoever, 2 big funds are going to rate SBTX soon. Free coverage from the states. I am hoping they value it at around 350p, with no decimal point to the left.

Are my posts really that messed up? At least it's not costing anyone anything . That's a positive I have found today

I dont know why my input is put in the same class as SBTX RNS's

I don't know why, but i could just feel al of your emotions as I read it. As if i was you reading it. Was like a knife in the back. I went out, put on the kettle and made a coffee. Then I thought for a few moments.

'What will I wear today'